Cargando…

The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer

Combination chemotherapy, either modified FOLFIRINOX (mFFX) or gemcitabine–nabpaclitaxel, are used in the treatment of most patients with advanced pancreatic ductal adenocarcinoma (PDAC), yet robust biomarkers of outcome are currently lacking to guide regimen selection. Here, we tested GATA6 immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Kai, Jang, Gun-Ho, Grant, Robert C., Wilson, Julie M., Notta, Faiyaz, O’Kane, Grainne M., Knox, Jennifer J., Gallinger, Steven, Fischer, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298486/ https://www.ncbi.nlm.nih.gov/pubmed/34294813 http://dx.doi.org/10.1038/s41598-021-94544-3

Ejemplares similares

Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis
por: Holzapfel, Nicholas, et al.
Publicado: (2023)

Advances in the management of pancreatic ductal adenocarcinoma
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Avancées dans la prise en charge de l’adénocarcinome canalaire pancréatique
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Determinants of gemcitabine response in pancreatic cancer: are we there?
por: Fitzpatrick, Orla M., et al.
Publicado: (2023)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023)

Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature
por: Lee, Cha Len, et al.
Publicado: (2022)

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma
por: Topham, James T., et al.
Publicado: (2022)

Diagnostic and Prognostic Roles of GATA3 Immunohistochemistry in Urothelial Carcinoma
por: Yoo, Daeseon, et al.
Publicado: (2023)

Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
por: Stossel, Chani, et al.
Publicado: (2023)

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
por: Golesworthy, Bryn, et al.
Publicado: (2022)

Mitochondrial fitness and cancer risk
por: Kossenkov, Andrew V., et al.
Publicado: (2022)

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)
por: Hosen, S. M. Zahid, et al.
Publicado: (2022)

Immunohistochemistry of mammary Paget’s disease: Cytokeratin 7, GATA3, and HER2 are sensitive markers
por: Arain, Shoukat A., et al.
Publicado: (2020)

Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers
por: Romero, Joan Miguel, et al.
Publicado: (2023)

Widespread hypertranscription in aggressive human cancers
por: Zatzman, Matthew, et al.
Publicado: (2022)

Plasmacytoid Urothelial Carcinoma of the Urinary Bladder Metastatic to the Duodenum: A Case Report—Diagnostic Relevance of GATA3 Immunohistochemistry
por: Brustmann, Hermann
Publicado: (2017)

NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4
por: Jain, Pallavi, et al.
Publicado: (2021)

Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
por: Luu, Tuan Trong
Publicado: (2021)

The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma
por: Heredia-Soto, Victoria, et al.
Publicado: (2023)

p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma
por: Hur, Stella K., et al.
Publicado: (2023)

Computer-assisted three-dimensional reconstruction of the fetal pancreas including the supplying arteries according to immunohistochemistry of pancreatic polypeptide
por: Yu, Hee Chul, et al.
Publicado: (2011)

Value of immunohistochemistry in the diagnosis of malignant cervical lymph nodes
por: de Natale Caly, Décio, et al.
Publicado: (2015)

GATA4 inhibits cell differentiation and proliferation in pancreatic cancer
por: Gong, Yan, et al.
Publicado: (2018)

Comprehensive Analysis of Expression and Prognostic Value of GATAs in Lung Cancer
por: Gong, Chengwu, et al.
Publicado: (2021)

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
por: Barnes, Tristan A., et al.
Publicado: (2017)

GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression
por: Jiang, Weiliang, et al.
Publicado: (2021)

The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
por: Klevesath, M B, et al.
Publicado: (2005)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies
por: Guimond, Elizabeth, et al.
Publicado: (2022)

A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma
por: Aung, Kyaw L., et al.
Publicado: (2022)

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1
por: Singh, Preeti, et al.
Publicado: (2021)

Combination of Immunohistochemistry and Ploidy Analysis to Assist Histopathological Diagnosis of Molar Diseases
por: Osterheld, M.C., et al.
Publicado: (2008)

Pancreatic paraganglioma: An extremely rare entity and crucial role of immunohistochemistry for diagnosis
por: Borgohain, Mondita, et al.
Publicado: (2013)

La gata /
por: Colette, 1873-1954
Publicado: (1983)

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Khalvati, Farzad, et al.
Publicado: (2019)

Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Zhang, Yucheng, et al.
Publicado: (2020)

Novel GATA6 Mutations in Patients with Pancreatic Agenesis and Congenital Heart Malformations
por: Chao, Christina S., et al.
Publicado: (2015)

GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway
por: Chang, Zhenyu, et al.
Publicado: (2019)

Retraction: GATA4 regulates inflammation-driven pancreatic ductal adenocarcinoma progression
Publicado: (2023)

How scientists interpret and address funding criteria: value creation and undesirable side effects
por: O’Kane, Conor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pkeeu6fcmsjcdoe4r16dn6i3fj